众生药业：公司的股东情况敬请留意公司定期报告

Core Viewpoint - The company, Zhongsheng Pharmaceutical (002317), addressed investor inquiries on November 20, indicating that shareholders should refer to the company's periodic reports for detailed information [1]. Group 1 - The company is actively engaging with investors through an interactive platform [1]. - The company emphasizes the importance of periodic reports for understanding shareholder information [1].